Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status. Pett SL, Spyer M, Haddow LJ, Nhema R, et al. AIDS 2021;35:585-594.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pett SL, Spyer M, Haddow LJ, Nhema R, et al. Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status. AIDS 2021;35:585-594.
PMID: 33306556